Assessment of Diaphragmatic Mobility in Dyspneic Patients With Different Types of Interstitial Lung Diseases

NCT ID: NCT07131072

Last Updated: 2025-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

dyspnea and impaired exercise capacity in IPF patients can be related, at least in part, to respiratory muscle dysfunction, in particular to diaphragm functionality. Both B-mode and M-mode ultrasound techniques have been employed to assess diaphragm excursion, which measures the distance that the diaphragm is able to move during the respiratory cycle.

recent study using lung ultrasound in assessment of diaphragmatic mobility in IPF patients and found that Diaphragmatic mobility is lower in IPF patients than in healthy controls, especially during deep inspiration. The correlation between reduced FVC and diaphragmatic excursion values in IPF patients can be of interest, since it could represent an index of functional respiratory affection performed by chest ultrasound

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interstitial lung diseases are known to be associated with limitations in daily activities and impaired quality of life. One of the most troublesome burdens for ILD patients is dyspnea during exercise, which extends to the resting state as the disease advances. The causes of dyspnea are suggested to be a progressive decline in total lung capacity (TLC) and vital capacity, along with impairment of diffusion capacity and subsequent development of (primarily hypoxic) respiratory failure along with respiratory muscle dysfunction.

Studies have supported the advantage of ultrasonography in the assessment of diaphragmatic mobility by two-dimensional (BD) or M-mode. Others reported the investigation methods, the criteria for normal and pathological diaphragmatic function, and the perspectives of development in adult patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diaphragm Issues

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

collagen related interstitial lung disease

daiphragm mobility by ultrsound

Intervention Type OTHER

fibrosis score, alveolitis score by CT Chest

spirometry ,DLCo

Intervention Type OTHER

FEV1, FVC, FEV1/FVC, DLCo

idiopathic type (IPF)

daiphragm mobility by ultrsound

Intervention Type OTHER

fibrosis score, alveolitis score by CT Chest

spirometry ,DLCo

Intervention Type OTHER

FEV1, FVC, FEV1/FVC, DLCo

OTHERS(occupational,sarcoid,...)

daiphragm mobility by ultrsound

Intervention Type OTHER

fibrosis score, alveolitis score by CT Chest

spirometry ,DLCo

Intervention Type OTHER

FEV1, FVC, FEV1/FVC, DLCo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

daiphragm mobility by ultrsound

fibrosis score, alveolitis score by CT Chest

Intervention Type OTHER

spirometry ,DLCo

FEV1, FVC, FEV1/FVC, DLCo

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

warricks score

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients presented to Ain Shams University Hospital outpatient clinic by ILD due to any cause

Exclusion Criteria

* Pregnant females
* Patients with end stage organ failure e.g.: Renal failure, liver cell failure
* Patients with malignancy elsewhere.
* The patients who refuse to be entitled in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

hieba gamal ezz-elragal awad

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ain Shams university

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMASU R13/2021

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.